首页> 外文期刊>AIDS >Broad usage spectrum of G protein-coupled receptors as coreceptors by primary isolates of HIV
【24h】

Broad usage spectrum of G protein-coupled receptors as coreceptors by primary isolates of HIV

机译:HIV的主要分离株广泛使用G蛋白偶联受体作为共受体

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: HIV-1 can use various G protein-coupled receptors (GPCRs) in addition to CCR5 and CXCR4 as coreceptors; however, this type of HIV-1 infection has hardly been detected in vivo. The objective of this study was to elucidate the spectrum of GPCR usage by HIV-1 populations in vivo.Design: CD4-expressing glioma cell line, NP-2/CD4, becomes highly susceptible to HIV-1 when the cells express GPCRs with coreceptor activities. This cell system was advantageous for detecting the inefficient use of GPCRs by HIV-1.Methods: We developed NP-2/CD4/GPCR cells that express each of 23 GPCRs: 21 chemokine receptors (CCR1, CCR2b, CCR3, CCR4, CCR5, CCR6, CCR7, CCR8, CCR9B, CCR10, CCR11, CXCR1, CXCR2, CXCR3, CXCR4, CXCR5, CXCR6, CX3CR1, XCR1, D6, and DARC) and two other GPCRs (a formylpeptide receptor, FPRL1, and an orphan GPCR, GPR1). NP-2/CD4/GPCR cells were directly cocultured with HIV-1-positive peripheral blood lymphocytes and HIV-1 infection was detected.Results: Primary HIV-1 isolates were obtained from NP-2/CD4/GPCR cells expressing CCR5, CXCR4, FPRL1, or GPR1 cocultured with 11 of 17 peripheral blood lymphocytes. Surprisingly, these isolates showed extremely expanded GPCR usage, such as CCR1, CCR3, CCR5, CCR8, CXCR4, D6, FPRL1, and GPR1 as coreceptors. We found that CCR9B, CCR10, and XCR1 also work as novel HIV-1 coreceptors.Conclusion: FPRL1 and GPR1 have the potential to work as significant HIV-1 coreceptors in vivo next to CCR5 and CXCR4. HIV-1 populations that can use various GPCRs as coreceptors are already circulating in vivo, even in the early stage of HIV-1 infection.
机译:目的:HIV-1除了可以使用CCR5和CXCR4作为共受体之外,还可以使用多种G蛋白偶联受体(GPCR)。然而,这种HIV-1感染在体内几乎没有被检测到。这项研究的目的是阐明体内HIV-1人群使用GPCR的谱图。设计:当CD4表达具有共同受体的GPCR时,表达CD4的神经胶质瘤细胞株NP-2 / CD4对HIV-1高度敏感。活动。该细胞系统有利于检测HIV-1对GPCR的无效使用。方法:我们开发了NP-2 / CD4 / GPCR细胞,该细胞表达23种GPCR中的每一种:21种趋化因子受体(CCR1,CCR2b,CCR3,CCR4,CCR5, CCR6,CCR7,CCR8,CCR9B,CCR10,CCR11,CXCR1,CXCR2,CXCR3,CXCR4,CXCR5,CXCR6,CX3CR1,XCR1,D6和DARC)和其他两个GPCR(甲酰基肽受体,FPRL1和孤儿GPCR) )。将NP-2 / CD4 / GPCR细胞与HI​​V-1阳性外周血淋巴细胞直接共培养,并检测HIV-1感染。结果:从表达CCR5,CXCR4的NP-2 / CD4 / GPCR细胞中分离出原代HIV-1。 ,FPRL1或GPR1与17种外周血淋巴细胞中的11种共培养。令人惊讶的是,这些分离株显示出极大扩展的GPCR用途,例如CCR1,CCR3,CCR5,CCR8,CXCR4,D6,FPRL1和GPR1作为共受体。我们发现CCR9B,CCR10和XCR1还可作为新型HIV-1受体。结论:FPRL1和GPR1在体内具有潜在的重要HIV-1受体的作用,仅次于CCR5和CXCR4。可以使用各种GPCR作为共受体的HIV-1人群已经在体内传播,即使在HIV-1感染的早期也是如此。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号